Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,714,313
-
Share change
-
+1,012,932
-
Total reported value
-
$117,833,102
-
Price per share
-
$12.13
-
Number of holders
-
41
-
Value change
-
+$12,345,696
-
Number of buys
-
31
-
Number of sells
-
7
Institutional Holders of PROTEOSTASIS THERAPEUTICS IN - COM (PTI) as of Q2 2016
As of 30 Jun 2016,
PROTEOSTASIS THERAPEUTICS IN - COM (PTI) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,714,313 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, Cormorant Asset Management, LLC, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, Rock Springs Capital Management LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, EVENTIDE ASSET MANAGEMENT, LLC, and BlackRock Fund Advisors.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.